Home

TARGET N V BIOTECH

CIK 1259870 · last filed 2024-11-18

TARGET N V BIOTECH is a corporate insider who has filed 13 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing, for MTEM, was dated Nov 18, 2024. Across all open-market trades the lifetime net is +$55.3M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $40.0M across reported positions. 72 SEC filings were submitted jointly with BB BIOTECH AG.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$39.95M

Companies

4

Total Filings

13

Lifetime Open-Market Net

$55.32M

Filer Profile

Reported Address
ARA HILL TOP BUILDING, UNIT A-5
PLETTERIJWEG OOST 1, CURACAO
WILLEMSTAD, P8 000000
Related Filers
BB BIOTECH AG — 72 joint filings, latest 2024-11-18
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Molecular Templates, Inc. (MTEM) Delisted 10%+ Owner 0 $0.00 $0 $15.26M 6 2024-11-18
MGNX 10%+ Owner 9,079,963 $4.40 $39.95M $10.68M 3 2023-01-23
Radius Health, Inc. (RDUS) Delisted 10%+ Owner 8,255,714 $30.00 $247.67M $6.94M 1 2022-01-07
Esperion Therapeutics, Inc. (ESPR) Delisted 10%+ Owner 3,652,964 $3.18 $11.62M $22.44M 3 2019-09-06

Recent Filings

13 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-11-18 Molecular Templates, Inc. (MTEM) Delisted Mixed −2,559,640 -$1.69M EDGAR
2023-07-19 Molecular Templates, Inc. (MTEM) Delisted Buy (P) +8,510,638 $4.00M EDGAR
2023-01-23 MGNX Buy (P) +300,000 $1.59M EDGAR
2022-12-28 MGNX Buy (P) +800,000 $4.60M EDGAR
2022-10-25 MGNX Buy (P) +1,000,000 $4.50M EDGAR
2022-01-07 Radius Health, Inc. (RDUS) Delisted Buy (P) +1,100,000 $6.94M EDGAR
2021-07-21 Molecular Templates, Inc. (MTEM) Delisted Buy (P) +488,764 $3.45M EDGAR
2021-04-13 Molecular Templates, Inc. (MTEM) Delisted Buy (P) +571,328 $4.68M EDGAR
2021-02-01 Molecular Templates, Inc. (MTEM) Delisted Buy (P) +160,000 $1.91M EDGAR
2020-11-12 Molecular Templates, Inc. (MTEM) Delisted Buy (P) +320,000 $2.91M EDGAR
Showing 1–10 of 13
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.